Axsome Therapeutics shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by MPM Oncology Impact Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $4.2M | 50k | 84.61 |
| 2024-06-30 | $11M | 132k | 80.50 |
| 2024-03-31 | $9.1M | 114k | 79.80 |
| 2023-09-30 | $6.5M | 94k | 69.89 |
| 2023-06-30 | $6.7M | 94k | 71.86 |
| 2023-03-31 | $4.3M | 70k | 61.68 |
| 2022-12-31 | $4.0M | 52k | 77.13 |
| 2022-03-31 | $4.1M | 100k | 41.39 |
| 2021-12-31 | $3.9M | 103k | 37.78 |
| 2021-09-30 | $3.6M | 110k | 32.96 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management